188 related articles for article (PubMed ID: 38241373)
1. MCJ: A mitochondrial target for cardiac intervention in pulmonary hypertension.
Santamans AM; Cicuéndez B; Mora A; Villalba-Orero M; Rajlic S; Crespo M; Vo P; Jerome M; Macías Á; López JA; Leiva M; Rocha SF; León M; Rodríguez E; Leiva L; Pintor Chocano A; García Lunar I; García-Álvarez A; Hernansanz-Agustín P; Peinado VI; Barberá JA; Ibañez B; Vázquez J; Spinelli JB; Daiber A; Oliver E; Sabio G
Sci Adv; 2024 Jan; 10(3):eadk6524. PubMed ID: 38241373
[TBL] [Abstract][Full Text] [Related]
2. Role of Hypoxia-Inducible Factors in Regulating Right Ventricular Function and Remodeling during Chronic Hypoxia-induced Pulmonary Hypertension.
Smith KA; Waypa GB; Dudley VJ; Budinger GRS; Abdala-Valencia H; Bartom E; Schumacker PT
Am J Respir Cell Mol Biol; 2020 Nov; 63(5):652-664. PubMed ID: 32692928
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of mTOR by rapamycin does not improve hypoxic pulmonary hypertension-induced right heart failure in old mice.
McNair BD; Schlatter JA; Cook RF; Yusifova M; Bruns DR
Exp Gerontol; 2021 Aug; 151():111395. PubMed ID: 33971279
[TBL] [Abstract][Full Text] [Related]
4. Sulforaphane prevents right ventricular injury and reduces pulmonary vascular remodeling in pulmonary arterial hypertension.
Kang Y; Zhang G; Huang EC; Huang J; Cai J; Cai L; Wang S; Keller BB
Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H853-H866. PubMed ID: 32108526
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the Fucoidan/P-Selectin Axis as a Therapeutic Target in Hypoxia-induced Pulmonary Hypertension.
Novoyatleva T; Kojonazarov B; Owczarek A; Veeroju S; Rai N; Henneke I; Böhm M; Grimminger F; Ghofrani HA; Seeger W; Weissmann N; Schermuly RT
Am J Respir Crit Care Med; 2019 Jun; 199(11):1407-1420. PubMed ID: 30557519
[No Abstract] [Full Text] [Related]
6. MAP kinase kinase kinase-2 (MEKK2) regulates hypertrophic remodeling of the right ventricle in hypoxia-induced pulmonary hypertension.
Brown RD; Ambler SK; Li M; Sullivan TM; Henry LN; Crossno JT; Long CS; Garrington TP; Stenmark KR
Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H269-81. PubMed ID: 23125215
[TBL] [Abstract][Full Text] [Related]
7. Functional and molecular determinants of right ventricular response to severe pulmonary hypertension in a large animal model.
Brown RD; Hunter KS; Li M; Frid MG; Harral J; Krafsur GM; Holt TN; Williams J; Zhang H; Riddle SR; Edwards MG; Kumar S; Hu CJ; Graham BB; Walker LA; Garry FB; Buttrick PM; Lahm T; Kheyfets VO; Hansen KC; Stenmark KR
Am J Physiol Heart Circ Physiol; 2023 Jun; 324(6):H804-H820. PubMed ID: 36961489
[TBL] [Abstract][Full Text] [Related]
8. Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1α.
Ball MK; Waypa GB; Mungai PT; Nielsen JM; Czech L; Dudley VJ; Beussink L; Dettman RW; Berkelhamer SK; Steinhorn RH; Shah SJ; Schumacker PT
Am J Respir Crit Care Med; 2014 Feb; 189(3):314-24. PubMed ID: 24251580
[TBL] [Abstract][Full Text] [Related]
9. Direct and indirect protection of right ventricular function by estrogen in an experimental model of pulmonary arterial hypertension.
Liu A; Schreier D; Tian L; Eickhoff JC; Wang Z; Hacker TA; Chesler NC
Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H273-83. PubMed ID: 24906919
[TBL] [Abstract][Full Text] [Related]
10. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
[TBL] [Abstract][Full Text] [Related]
11. Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension.
Xu EZ; Kantores C; Ivanovska J; Engelberts D; Kavanagh BP; McNamara PJ; Jankov RP
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1854-64. PubMed ID: 20889845
[TBL] [Abstract][Full Text] [Related]
12. Dehydroepiandrosterone restores right ventricular structure and function in rats with severe pulmonary arterial hypertension.
Alzoubi A; Toba M; Abe K; O'Neill KD; Rocic P; Fagan KA; McMurtry IF; Oka M
Am J Physiol Heart Circ Physiol; 2013 Jun; 304(12):H1708-18. PubMed ID: 23585128
[TBL] [Abstract][Full Text] [Related]
13. Metformin protects against pulmonary hypertension-induced right ventricular dysfunction in an age- and sex-specific manner independent of cardiac AMPK.
McNair BD; Polson SM; Shorthill SK; Yusifov A; Walker LA; Weiser-Evans MCM; Kovacs EJ; Bruns DR
Am J Physiol Heart Circ Physiol; 2023 Aug; 325(2):H278-H292. PubMed ID: 37389952
[TBL] [Abstract][Full Text] [Related]
14. Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia.
Brusselmans K; Compernolle V; Tjwa M; Wiesener MS; Maxwell PH; Collen D; Carmeliet P
J Clin Invest; 2003 May; 111(10):1519-27. PubMed ID: 12750401
[TBL] [Abstract][Full Text] [Related]
15. Baicalin attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A
Huang X; Wu P; Huang F; Xu M; Chen M; Huang K; Li GP; Xu M; Yao D; Wang L
J Biomed Sci; 2017 Aug; 24(1):52. PubMed ID: 28774332
[TBL] [Abstract][Full Text] [Related]
16. Identification of Celastrol as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension and Right Ventricular Failure Through Suppression of Bsg (Basigin)/CyPA (Cyclophilin A).
Kurosawa R; Satoh K; Nakata T; Shindo T; Kikuchi N; Satoh T; Siddique MAH; Omura J; Sunamura S; Nogi M; Takeuchi Y; Miyata S; Shimokawa H
Arterioscler Thromb Vasc Biol; 2021 Mar; 41(3):1205-1217. PubMed ID: 33472404
[TBL] [Abstract][Full Text] [Related]
17. YC-1 attenuates hypoxia-induced pulmonary arterial hypertension in mice.
Huh JW; Kim SY; Lee JH; Lee YS
Pulm Pharmacol Ther; 2011 Dec; 24(6):638-46. PubMed ID: 21963997
[TBL] [Abstract][Full Text] [Related]
18. p53 Gene deficiency promotes hypoxia-induced pulmonary hypertension and vascular remodeling in mice.
Mizuno S; Bogaard HJ; Kraskauskas D; Alhussaini A; Gomez-Arroyo J; Voelkel NF; Ishizaki T
Am J Physiol Lung Cell Mol Physiol; 2011 May; 300(5):L753-61. PubMed ID: 21335523
[TBL] [Abstract][Full Text] [Related]
19. Smooth muscle Rac1 contributes to pulmonary hypertension.
Dilasser F; Rio M; Rose L; Tesse A; Guignabert C; Loirand G; Sauzeau V
Br J Pharmacol; 2022 Jul; 179(13):3418-3429. PubMed ID: 35064565
[TBL] [Abstract][Full Text] [Related]
20. Smooth muscle protein 22alpha-mediated patchy deletion of Bmpr1a impairs cardiac contractility but protects against pulmonary vascular remodeling.
El-Bizri N; Wang L; Merklinger SL; Guignabert C; Desai T; Urashima T; Sheikh AY; Knutsen RH; Mecham RP; Mishina Y; Rabinovitch M
Circ Res; 2008 Feb; 102(3):380-8. PubMed ID: 18079409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
